United States Patent Olhce Patented Aug

Total Page:16

File Type:pdf, Size:1020Kb

United States Patent Olhce Patented Aug 3,597,360 United States Patent Olhce Patented Aug. 3, 11971 l 2 ?ora is maintained even after three: hours of Wearing sur 3,597,360 gical gloves. The disinfectant is in the form of a liquid or SURGICAL SCRUB Galen F. Collins, Bristol, Tenn, and Fred S. Barr and solid soap formulation containing a detergent and a bac Charles F. Bullock, Bristol, Va., assignors to The S. E. teriostat. Bacteriostasis is produced herein by nitromersol. Massengill Company, Bristol, Tenn. No Drawing. Filed May 2, 1968, Ser. No. 726,215 DETAILED DESCRIPTION OF THE INVENTION Int. Cl. Clld 3/48, 3/50 US. Cl. 252-106 3 Claims Various chemical disinfectants can reduce bacterial colonization for a brief period of time. However even his phenols of the hexachlorophene type and iodine when in 10 corporated in scrubs remove only part of the transient ABSTRACT OF THE DISCLOSURE bacteria. Other transient bacteria, along with resident bac Various chemical disinfectants can reduce bacterial teria, remain and multiply within a few hours, so that the colonization for a brief period of time. However even bis bacterial ?ora builds back up. For hospital workers, it phenols of the hexachlorophene type and iodine when in would, therefore, be desirable to have a more effective corporated in scrubs remove only part of the transient scrub product. bacteria. Other transient bacteria, along with resident bac The fact that the scrub contemplated herein is effec teria, remain and multiply within a few hours, so that the tive over a longer period than those now known is quite bacterial ?ora builds back up. For hospital workers, it surprising in view of in vitro tests which show very little would, therefore, be desirable to have a more effective bactericidal difference between nitromersol and other or scrub product. The scrub contemplated herein is effective 20 ganomercurial antimicrobials. Equally surprising is the over a longer period than those now known. fact that nitromersol by itself is effective in maintaining a low bacterial ?ora. As shown in our copending applica tion ?led concurrently herewith, combinations of diphenyl BACKGROUND OF THE INVENTION and organomercurial antimicrobials maintain a low bac~ 25 terial ?ora for over three hours whereas antimicrobials Much has been written about the bacteriology of the alone do not. Nitromersol, however, has been found to be skin. In fact, one of the greatest factors in cross-infections an exception. is considered by many to be bacteria on hands. The trans Broadly the invention contemplates the use of nitro mitting of cross-infections by bacteria on hands has been mersol in a liquid or solid detergent to form a soap for found even greater than that by airborne bacteria or nasal topical use. However the detergent-antimicrobial com Staph-carriers. Scrubbing with a soap reduces bacterial position will generally include skin conditioners and ?ora logarithmically, about one-half each six minutes. the like. For the purpose of illustration a desirable However it is well known that the use of a disinfectant in liquid base formulation is set forth in Example a. The base the soap reduces bacterial colonization in a briefer period 35 contains a highly concentrated, neutral, anionic synthetic of time and to a greater extent. detergent whose active ingredient is a modi?ed lauryl sul Since complete skin sterilization is not feasible, the im fate plus an amide builder. Additionally included is a neu portance of scrubbing preparations having both an anti tral, essentially nonionic, self-emulsifying, fatty-based bacterial effect and a detergent elfect in reducing the num ester derived from glycerides and particularly suited for ber of bacteria on skin is well established, particularly for 40 handwashing preparations. Lanolins can also be incorpo surgeons, obstricians, and examining physicians, as well rated in liquid scrubs, so modi?ed that they are water as nurses and those applying therapy and dispensing food soluble, essentially nonionic detergents. Polypropylene and medication. Numerous surgical scrub products are on glycol and perfume can also be used in liquid scrubs as the market, and most of these contain hexachlorophene or illustrated herein. iodine bacteriostats in one form or another. However 45 This invention can perhaps best be illustrated by com studies with hexachlorophene and iodine show that these parative examples. In these examples, compositions as well scrub preparations lose their effectiveness in time, due to as bacterial counts before and after scrubbing are given. the build-up of bacterial ?ora, particularly when the To determine its effectiveness in reducing the number of scrubbed hands are gloved. Results obtained indicate that bacteria on hands, the base as well. as antibacterial deter within three hours after washing with these soaps the 50 gents were tested using a slightly modi?ed standard pro antibacterial effect disappears. This is especially signi? cedure. The right hand of each subject was placed in a cant in view of the fact that one-third of surgical gloves sterile 1000 m1. plastic bag and 300 ml, of sterile 0.85% are punctured during the course of an operation. saline was added. The hand was shaken vigorously for three minutes. Following the shaking process, the bac~ SUMMARY OF THE INVENTION 55 terial counts were run by standard methods, diluting the saline and plating in petri dishes with MPH Medium Since hexachlorophene and iodine scrubs have very lit (BBL). The plates were incubated at 37° C. for 72 hours. tle bactericidal effect at the end of three hours, it has The number of bacteria per hand (per 300 ml.) are re been proposed that some antibacterial procedure be ported. Following the initial count, the hands were adopted by surgeons and attending nurses after two hours, 60 scrubbed for 4 minutes with the test products, followed by for instance a seventy percent alcohol rinse, and a change rinsing in tap water. When the scrub was completed the to new gloves. right hand was placed in a rubber glove and a bacterial According to the practice of this invention such meas count was conducted on the left hand. The right hand was ures would not be necessary. An antibacterial skin disin allowed to remain in the glove for three hours and then fectant is provided by which an unusually low bacterial a bacterial count was conducted on it. 3,597,360 3 4 Example a ' Percent Part I: Percent Subject Pro-scrub Post-scrub reduction Alkyl sulfate ______________ ....- _________ __ 18-5 1 7 10“ 0 100 Alkanolamide ________________________ .._ 4.5 735E100 5.4X10e 3g Unsulfatcd alcohol _____________________ __ 0.6 5 4 g’: 8 igg Ammonium sulfate ____________________ __ 0.5 5 _____________ ._ 13_s><10@ 0 100 Ammonium chloride ___________________ __ 0.5 Denatilreq ethyl alcohol.''''' 'T““".'""‘." 10'0 Organic mercurial antimicrobial agents are well known. C°mbma;tw_n of 1110150, d1’ and mglycéndes Wlth 10 Hence the preparation or other source of nitromersol a nomomc emulsi?er k--1--"1-"1-_------- -- i (metaphen—CqH5HgNO3) need not be discussed. l_\Ior Water Soluble Polyoxyal y ‘me am) m ----- -- ' mally the scrubbing composition, regardless of ingredients Propylene glycol ----------------------- -- 6‘0 other than the detergent, will contain 0.01 to 1 percent, Perfume ----------------------------- -- 0'1 preferably 0.1 to 0.5 percent, nitromersol by weight based 46 7 15 on the composition. _ ' As indicated hereinbefore, reductions of bacterial ?ora H_ immediately after scrubbing are virtually the same when Part ' 53 3 the organomercurial and bisphenolic antimicrobials are Water """"""""""""""""""""" " ' used. However they do not hold the count down. This 100 00 20 will be apparent from Table I wherein hexachlorophene ' (HEXA), Phenylmercuric acetate (PMA), and other an Procedure.—The ingredients in Part I on a weight basis timicrobials are compared after gloves are worn three are combined and heated to 60° C. to 70° C. using a hours. Averages of at least ?ve determinations are given. TABLE I Bacterial count after scrub Bacterial count after three hours in glove Pre-scrub Post-scrub Percent Pre-scrub Post-glove Percent Active ingredient count count change count count change 3. 86><10° 1. 08x105 —97 3. 86X10° 8. 56x10“ +221 4.1><10? 1. 56X105 —96 4.1><10? 2. 25x105 —46 8. 5x108 2. 29x10“ —73 8. 5x106 9. 3x106 +109 _ 1. 77x10‘l 2. 38X105 —87 1.77Xl0° 1. 46><l06 —17 Nitromersol _________________ ._ 4. 87x106 1. 025x108 —78 4. 87x108 1. 24><1u? —75 water bath and stirring means to make a solution. The Whereas hexachlorophene reduces the bacterial count water, Part H, is then slowly blended in, the composition 97 percent after the scrub, the duration of the effectiveness being gently agitated to prevent incorporation of air into is short. After the glove has been on the hand three hours the product. the count is 221 percent higher than it was prior to the scrub. Phenylmercuric acetate (PMA) is somewhat more effective, the reduction in bacterial count being 96 percent 50 post-scrub, but only 46 percent at the end of three hours. Percent However the reduction in bacterial count after three Subject Pre-scrub Post‘scrub reduction hours is still 75 percent in the case of nitromersol. 2. 8X105 2. 0x104 93 The fact that nitromersol maintains a low bacterial 2. 1x106 7. 0x104 99 2. 4X105 1. 8x104 93 ?ora on the skin was also unexpected in the light of in 5. 5x104 3. 0X104 94 55 vitro work with the antimicrobials. As will be seen in 2. 1X105 1. 2X104 93 Table II there is very little di?erence in in vitro activity Average. _ 5. 77x105 8. 0x104 95 between the bisphenolic and organomercurial antimicro bials. The in vitro work with these products was carried out against Candida albicans and Staphylococcus aureus by When antimicrobials are incorporated in the base, a a tube dilution method.
Recommended publications
  • Selling Mercury Cosmetics and Pharmaceuticals (W-Hw4-22)
    www.pca.state.mn.us Selling mercury cosmetics and pharmaceuticals Mercury-containing skin lightening creams, lotions, soaps, ointments, lozenges, pharmaceuticals and antiseptics Mercury is a toxic element that was historically used in some cosmetic, pharmaceutical, and antiseptic products due to its unique properties and is now being phased out of most uses. The offer, sale, or distribution of mercury-containing products is regulated in Minnesota by the Minnesota Pollution Control Agency (MPCA). Anyone offering a mercury-containing product for sale or donation in Minnesota is subject to these requirements, whether a private citizen, collector, non-profit organization, or business. Offers and sales through any method are regulated, whether in a store or shop, classified advertisement, flea market, or online. If a mercury-containing product is located in Minnesota, it is regulated, regardless of where a purchaser is located. Note: This fact sheet discusses the requirements and restrictions of the MPCA. Cosmetics and pharmaceuticals may also be regulated for sale whether they contain mercury or not by other state or federal agencies, including the Minnesota Board of Pharmacy and the U.S. Food & Drug Administration. See More information on page 2. What are the risks of using mercury-containing products? Use of mercury-containing products can damage the brain, kidneys, and liver. Children and pregnant women are at increased risk. For more information about the risks of mercury exposure, visit the Minnesota Department of Health. See More information on the page 2. If you believe you have been exposed to a mercury-containing product, contact your health care provider or the Minnesota Poison Control Center at 1-800-222-1222.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0115729 A1 Qin Et Al
    US 201201.15729A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0115729 A1 Qin et al. (43) Pub. Date: May 10, 2012 (54) PROCESS FOR FORMING FILMS, FIBERS, Publication Classification AND BEADS FROM CHITNOUS BOMASS (51) Int. Cl (75) Inventors: Ying Qin, Tuscaloosa, AL (US); AOIN 25/00 (2006.01) Robin D. Rogers, Tuscaloosa, AL A6II 47/36 (2006.01) AL(US); (US) Daniel T. Daly, Tuscaloosa, tish 9.8 (2006.01)C (52) U.S. Cl. ............ 504/358:536/20: 514/777; 426/658 (73) Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF 57 ABSTRACT ALABAMA, Tuscaloosa, AL (US) (57) Disclosed is a process for forming films, fibers, and beads (21) Appl. No.: 13/375,245 comprising a chitinous mass, for example, chitin, chitosan obtained from one or more biomasses. The disclosed process (22) PCT Filed: Jun. 1, 2010 can be used to prepare films, fibers, and beads comprising only polymers, i.e., chitin, obtained from a suitable biomass, (86). PCT No.: PCT/US 10/36904 or the films, fibers, and beads can comprise a mixture of polymers obtained from a suitable biomass and a naturally S3712). (4) (c)(1), Date: Jan. 26, 2012 occurring and/or synthetic polymer. Disclosed herein are the (2), (4) Date: an. AO. films, fibers, and beads obtained from the disclosed process. O O This Abstract is presented solely to aid in searching the sub Related U.S. Application Data ject matter disclosed herein and is not intended to define, (60)60) Provisional applicationpp No. 61/182,833,sy- - - s filed on Jun.
    [Show full text]
  • United States Patent (19) 11 Patent Number: 5,753,634 Ebetino Et Al
    USOO5753634A United States Patent (19) 11 Patent Number: 5,753,634 Ebetino et al. 45 Date of Patent: May 19, 1998 54 QUATERNARY NITROGEN CONTAINING 4.011777 10/1990 Germany. PHOSPHONATE COMPOUNDS, WO 90/12017 10/1990 WIPO PHARMACEUTICAL COMPOSTIONS, AND WO 91/10646 7/1991 WIPO. METHODS FOR TREATING ABNORMAL Primary Examiner-Amelia Owens CALCUMAND PHOSPHATE METABOLISM Attorney, Agent, or Firm-Richard A. Hake; Karen F. Clark; William J. Winter 75 Inventors: Frank Hallock Ebetino; Marion David Francis, both of Cincinnati, 57 ABSTRACT Ohio; Susan Mary Kaas, Sherburne, Disclosed are quaternary nitrogen-containing, saturated or N.Y. unsaturated monocyclic and bicyclic ring-containing bis 73 Assignee: The Procter & Gamble Company, phosphonate compounds, and pharmaceutically-acceptable Cincinnati, Ohio salts and esters thereof. These compounds, which are useful for treating or preventing disorders of calcium and phos 21) Appl. No.: 52,694 phate metabolism, have the following general structure: 22) Filed: Apr. 30, 1993 (R), (CR2), (CR,): NY R Related U.S. Application Data 63 Continuation-in-part of Ser. No. 891,487, May 29, 1992, abandoned. 51 Int. Cl. ... A61K 31/675; A61K 31/66 52) U.S. Cl. ............................ 514/81: 514/91; 514/109: wherein 546/23: 548/111; 562/21 (a) each X and Y are independently selected from nil, O, 58 Field of Search ............................... 546/23: 514/80, S, NR' and N*(R); if no R' is N'(R), then at least 514/82, 91, 109; 548/111; 562/21 one of X or Y must be N(R); References Cited (b) m and n and m+n are integers from 0 to 5; p and q and 56 p+q are integers from 0 to 3; U.S.
    [Show full text]
  • Tepzz 459659B T
    (19) TZZ _T (11) EP 2 459 659 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: C09D 7/00 (2006.01) C09D 7/14 (2006.01) of the grant of the patent: C09D 5/16 (2006.01) 17.07.2013 Bulletin 2013/29 (86) International application number: (21) Application number: 10737728.5 PCT/US2010/043382 (22) Date of filing: 27.07.2010 (87) International publication number: WO 2011/017097 (10.02.2011 Gazette 2011/06) (54) REMOVABLEANTIMICROBIAL COATING COMPOSITIONS CONTAINING CATIONIC RHEOLOGY AGENT AND METHODS OF USE ABLÖSBARE ANTIMIKROBIELLE BESCHICHTUNGSZUSAMMENSETZUNGEN MIT KATIONISCHEM RHEOLOGISCHEM ADDITIV UND ANWENDUNGSVERFAHREN COMPOSITIONS DE REVÊTEMENT ANTIMICROBIENNES, APTES À ÊTRE RETIRÉES, CONTENANT UN AGENT DE RHÉOLOGIE CATIONIQUE, ET PROCÉDÉS D’UTILISATION (84) Designated Contracting States: (74) Representative: Dannenberger, Oliver Andre et al AL AT BE BG CH CY CZ DE DK EE ES FI FR GB Abitz & Partner GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO Patentanwälte PL PT RO SE SI SK SM TR Postfach 86 01 09 81628 München (DE) (30) Priority: 27.07.2009 US 228707 P 27.07.2009 US 228711 P (56) References cited: 27.07.2009 US 228715 P WO-A2-2007/100653 WO-A2-2007/100654 27.07.2009 US 228723 P 26.07.2010 US 843120 • Akzo Nobel Surface Chemistry: "Thickening with polymers"[Online] 1 January 2010 (2010-01-01), (43) Date of publication of application: XP002609717 Akzo Nobel Technical Information 06.06.2012 Bulletin 2012/23 Retrieved from the Internet: URL:http: //www.akzonobel.com/surface/syste m/images/ (73) Proprietor: E.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2002/0102215 A1 100 Ol
    US 2002O102215A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2002/0102215 A1 Klaveness et al. (43) Pub. Date: Aug. 1, 2002 (54) DIAGNOSTIC/THERAPEUTICAGENTS (60) Provisional application No. 60/049.264, filed on Jun. 6, 1997. Provisional application No. 60/049,265, filed (75) Inventors: Jo Klaveness, Oslo (NO); Pal on Jun. 6, 1997. Provisional application No. 60/049, Rongved, Oslo (NO); Anders Hogset, 268, filed on Jun. 7, 1997. Oslo (NO); Helge Tolleshaug, Oslo (NO); Anne Naevestad, Oslo (NO); (30) Foreign Application Priority Data Halldis Hellebust, Oslo (NO); Lars Hoff, Oslo (NO); Alan Cuthbertson, Oct. 28, 1996 (GB)......................................... 9622.366.4 Oslo (NO); Dagfinn Lovhaug, Oslo Oct. 28, 1996 (GB). ... 96223672 (NO); Magne Solbakken, Oslo (NO) Oct. 28, 1996 (GB). 9622368.0 Jan. 15, 1997 (GB). ... 97OO699.3 Correspondence Address: Apr. 24, 1997 (GB). ... 9708265.5 BACON & THOMAS, PLLC Jun. 6, 1997 (GB). ... 9711842.6 4th Floor Jun. 6, 1997 (GB)......................................... 97.11846.7 625 Slaters Lane Alexandria, VA 22314-1176 (US) Publication Classification (73) Assignee: NYCOMED IMAGING AS (51) Int. Cl." .......................... A61K 49/00; A61K 48/00 (52) U.S. Cl. ............................................. 424/9.52; 514/44 (21) Appl. No.: 09/765,614 (22) Filed: Jan. 22, 2001 (57) ABSTRACT Related U.S. Application Data Targetable diagnostic and/or therapeutically active agents, (63) Continuation of application No. 08/960,054, filed on e.g. ultrasound contrast agents, having reporters comprising Oct. 29, 1997, now patented, which is a continuation gas-filled microbubbles stabilized by monolayers of film in-part of application No. 08/958,993, filed on Oct.
    [Show full text]
  • Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act
    Updated June 07, 2021 Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Three categories of bulk drug substances: • Category 1: Bulk Drug Substances Under Evaluation • Category 2: Bulk Drug Substances that Raise Significant Safety Risks • Category 3: Bulk Drug Substances Nominated Without Adequate Support Updates to Categories of Substances Nominated for the 503B Bulk Drug Substances List1 • Add the following entry to category 2 due to serious safety concerns of mutagenicity, cytotoxicity, and possible carcinogenicity when quinacrine hydrochloride is used for intrauterine administration for non- surgical female sterilization: 2,3 o Quinacrine Hydrochloride for intrauterine administration • Revision to category 1 for clarity: o Modify the entry for “Quinacrine Hydrochloride” to “Quinacrine Hydrochloride (except for intrauterine administration).” • Revision to category 1 to correct a substance name error: o Correct the error in the substance name “DHEA (dehydroepiandosterone)” to “DHEA (dehydroepiandrosterone).” 1 For the purposes of the substance names in the categories, hydrated forms of the substance are included in the scope of the substance name. 2 Quinacrine HCl was previously reviewed in 2016 as part of FDA’s consideration of this bulk drug substance for inclusion on the 503A Bulks List. As part of this review, the Division of Bone, Reproductive and Urologic Products (DBRUP), now the Division of Urology, Obstetrics and Gynecology (DUOG), evaluated the nomination of quinacrine for intrauterine administration for non-surgical female sterilization and recommended that quinacrine should not be included on the 503A Bulks List for this use. This recommendation was based on the lack of information on efficacy comparable to other available methods of female sterilization and serious safety concerns of mutagenicity, cytotoxicity and possible carcinogenicity in use of quinacrine for this indication and route of administration.
    [Show full text]
  • Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act
    Updated July 30, 2020 Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Three categories of bulk drug substances: • Category 1: Bulk Drug Substances Under Evaluation • Category 2: Bulk Drug Substances that Raise Significant Safety Risks • Category 3: Bulk Drug Substances Nominated Without Adequate Support Notice of Updates to Categories of Substances Nominated for the 503B Bulk Drug Substances List • Additions to category 1: Betahistine Hydrochloride L-Proline Citrulline Papaverine Hydrochloride* Copper Gluconate Phosphatidylcholine Diiodohydroxyquinoline Podophyllum Resin Glucosamine Sulfate Potassium Chloride Sodium Molybdate Glucosamine Sulfate Sodium Chloride Sodium Nitroprusside Hydrochloric Acid* Sodium Selenite/Sodium Selenite Pentahydrate* Ibutamoren Mesylate Trichloroacetic Acid* L-Citrulline* Ubidecarenone (Coenzyme Q10)* L-Lysine * Bulk drug substance is currently in Category 3 and is being moved to Category 1. • Minor revision to entry in Category 1 to correct a misspelling: o Correct the misspelling of “cimatidine” to “cimetidine” 1 Updated July 30, 2020 503B Category 1: Bulk Drug Substances Under Evaluation • 5-Methyltetrahydrofolate Calcium • Chromic Chloride • 17-alpha-Hydroxyprogesterone • Chromium chloride/ Chromium Chloride • Acetylcysteine Hexahydrate • Acyclovir • Ciclopirox Oleate • Adapalene • Cimetidine • Adenosine • Ciprofloxacin HCl • Allantoin • Citric Acid Anhydrous • Alpha Lipoic Acid • Citrulline/L-Citrulline • Alprostadil • Clindamycin Phosphate
    [Show full text]
  • Assessment of the Antibiotic Resistance Effects of Biocides
    Scientific Committee on Emerging and Newly Identified Health Risks SCENIHR Assessment of the Antibiotic Resistance Effects of Biocides The SCENIHR adopted this opinion at the 28th plenary on 19 January 2009 after public consultation. 1 Antibiotic Resistance Effects of Biocides About the Scientific Committees Three independent non-food Scientific Committees provide the Commission with the scientific advice it needs when preparing policy and proposals relating to consumer safety, public health and the environment. The Committees also draw the Commission's attention to the new or emerging problems which may pose an actual or potential threat. They are: the Scientific Committee on Consumer Products (SCCP), the Scientific Committee on Health and Environmental Risks (SCHER) and the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), and are made up of external experts. In addition, the Commission relies upon the work of the European Food Safety Authority (EFSA), the European Medicines Evaluation Agency (EMEA), the European Centre for Disease prevention and Control (ECDC) and the European Chemicals Agency (ECHA). SCENIHR Questions concerning emerging or newly-identified risks and on broad, complex or multi- disciplinary issues requiring a comprehensive assessment of risks to consumer safety or public health and related issues not covered by other Community risk-assessment bodies. In particular, the Committee addresses questions related to potential risks associated with interaction of risk factors, synergic effects, cumulative effects, antimicrobial resistance, new technologies such as nanotechnologies, medical devices, tissue engineering, blood products, fertility reduction, cancer of endocrine organs, physical hazards such as noise and electromagnetic fields and methodologies for assessing new risks.
    [Show full text]
  • Disinfection of Gutta-Percha Cones Prior to Obturation: a Smattering of Historical Perspectives with a Focus on Contemporary Considerations
    REVIEW ARTICLE James L. Gutmann, Vivian Manjarrés Disinfection of gutta-percha cones prior to obturation: a smattering of historical perspectives with a focus on contemporary considerations KEY WORDS antibiotics, atomic force microscopy, chlorhexidine, culturing, decontamination, disinfection, glutaraldehyde, gutta-percha, NaOCl ABSTRACT The use of gutta-percha in dentistry and in particular root canal procedures has a long and tortu- ous history; its use has been the preferred obturation material of choice for well over a century, in spite of attempts to eliminate it for other entities that were erroneously perceived to be superior. However, because of the importance of asepsis and bacteriological control in the delivery of qual- ity root canal procedures, the clinical disinfection of gutta-percha cones has arisen as a controver- sial issue as to its need and the use of the most effective agent for rapid chairside management. This review will touch upon a brief history of the material and subsequently delve into the issues surrounding the decontamination/disinfection of this material in the hope to establish the best evidence for the clinical choice of managing this challenge. Introduction Royal Society of Arts, London, in 1843, for his con- tribution3. In 1845, Hancock and Bewley formed Gutta-percha comes from the trees of the genus the Gutta- Percha Company in the United King- Palaquium in the family Sapotaceae1, with the dom, and began to expand the uses of this material rigid natural latex produced from the sap of these over and above medical applications into a wide trees, in particular from Palaquium gutta. The variety of entities, with golf balls a prime product word gutta-percha is based on the plant’s name for over 50 years3.
    [Show full text]
  • Colloidal Dispersions
    0356 ch 021(293-318).ps 3/7/05 8:14 AM Page 293 CHAPTER 21 Colloidal Dispersions Bill J Bowman, PhD Clyde M Ofner III, PhD Hans Schott, PhD The British chemist Thomas Graham applied the term “colloid” An appreciable fraction of atoms, ions, or molecules of col- (derived from the Greek word for glue) ca 1850 to polypeptides loidal particles are located in the boundary layer between the such as albumin and gelatin; polysaccharides such as acacia, particle and the dispersion medium. The boundary layer be- starch, and dextrin; and inorganic compounds such as gelati- tween a particle and air is commonly referred to as a surface; nous metal hydroxides and Prussian blue (ferric ferrocyanide). whereas, the boundary layer between a particle and a liquid or Contemporary colloid and surface chemistry deals with an un- solid is commonly referred to as an interface. The ions/molecules usually wide variety of industrial and biological systems. A few within the particle and within the medium are surrounded on all examples include catalysts, lubricants, adhesives, latexes for side by similar ions/molecules and have balanced force fields; paints, rubbers and plastics, soaps and detergents, clays, ink, however, the ions/molecules at surfaces or interfaces are sub- packaging films, cigarette smoke, liquid crystals, drug delivery jected to unbalanced forces of attraction. Consequently, a surface systems, cell membranes, blood, mucous secretions, and aque- free energy component is added to the total free energy of col- ous humors.1–3 loidal particles and becomes important as the particles become smaller and a greater fraction of their atoms, ions, or molecules are located in the surface or interfacial region.
    [Show full text]
  • Kinetic and Mass-Spectrometric Studies of Atmospherically Relevant
    Kinetic and mass-spectrometric studies of atmospherically relevant mercury-bromine chemistry Elise-Andrée Guérette Department of Chemistry McGill University Montréal, Québec, Canada October 2010 A thesis submitted to McGill University in partial fulfilment of the require­ ments of the degree of Master of Science ©Elise-Andrée Guérette, 2010. All Rights Reserved. Acknowledgements My thanks go out to Dr. Daniel Deeds for his help with everything having to do with atmospheric pressure chemical ionization mass spectrometry. Working with you was always a pleasure. Alain Tessier from CBAMS at Concordia Univer­ sity was immensely helpful and creative in his problem solving. Thanks also to Graydon Snider for helpful discussions and helping me get started with the kinetic work. Edward Hudson, Nermin Eltouny, Daniel Deeds, Graydon Snider and Ma­ hamud Subir all proofread this thesis and provided helpful comments. I would also like to extend grateful thanks to my supervisor, Parisa Ariya, for her understanding and patience, and for providing me with this opportunity. Thanks also for reading this thesis before its submission and for providing valu­ able comments. Fred Kluck, Rick Rossi and George Kopp from the Department of Chemistry deserve mention for their help building and repairing things, often at short notice. Thanks also to FQRNT, the Department of Chemistry at McGill, and the Dr. and Mrs. Milton Leong fund for providing personal financial assistance during the course of my studies. Thanks last, but perhaps most of all, to my spouse, Craig Titchener, who stood by me every step of the way. Thank you. II Abstract Bromine radicals are thought to play an important role in the chemistry of atmospheric elemental mercury, however uncertainties remain concerning the rate and the mechanism of the reaction.
    [Show full text]
  • Kinetic and Mass-Spectrometric Studies of Atmospherically Relevant Mercury-Bromine Chemistry Elise-Andrée Guérette Department
    Kinetic and mass-spectrometric studies of atmospherically relevant mercury-bromine chemistry Elise-Andrée Guérette Department of Chemistry McGill University Montréal, Québec, Canada October 2010 A thesis submitted to McGill University in partial fulfilment of the require­ ments of the degree of Master of Science ©Elise-Andrée Guérette, 2010. All Rights Reserved. Acknowledgements My thanks go out to Dr. Daniel Deeds for his help with everything having to do with atmospheric pressure chemical ionization mass spectrometry. Working with you was always a pleasure. Alain Tessier from CBAMS at Concordia Univer­ sity was immensely helpful and creative in his problem solving. Thanks also to Graydon Snider for helpful discussions and helping me get started with the kinetic work. Edward Hudson, Nermin Eltouny, Daniel Deeds, Graydon Snider and Ma­ hamud Subir all proofread this thesis and provided helpful comments. I would also like to extend grateful thanks to my supervisor, Parisa Ariya, for her understanding and patience, and for providing me with this opportunity. Thanks also for reading this thesis before its submission and for providing valu­ able comments. Fred Kluck, Rick Rossi and George Kopp from the Department of Chemistry deserve mention for their help building and repairing things, often at short notice. Thanks also to FQRNT, the Department of Chemistry at McGill, and the Dr. and Mrs. Milton Leong fund for providing personal financial assistance during the course of my studies. Thanks last, but perhaps most of all, to my spouse, Craig Titchener, who stood by me every step of the way. Thank you. II Abstract Bromine radicals are thought to play an important role in the chemistry of atmospheric elemental mercury, however uncertainties remain concerning the rate and the mechanism of the reaction.
    [Show full text]